AstraZeneca to boost annual dividend by 7%
…
60,750€
0,41%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca unveils dividend hike ahead of CEO pay vote at AGM By Reuters
AstraZeneca unveils dividend hike ahead of CEO pay vote at AGM…
AstraZeneca increases 2024 dividend by 7%
11 April 2024
AstraZeneca increases 2024 dividend by 7%
AstraZeneca announced today that the Board intends to increase the annualised dividend for…
Ihre wichtigsten Termine: Heute im Blick: AstraZeneca, Frosta, Givaudan, VAT, Gerresheimer, Adecco & Emmi
© Foto: picture alliance/ASSOCIATED PRESS/Gerresheimer AG - picture alliance/ASSOCIATED PRESS/Gerresheimer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie…
AstraZeneca pay debate exposes disparity in US-UK corporate values
Tomorrow’s shareholder vote on AstraZeneca PLC (LSE:AZN) boss Pascal Soriot’s compensation represents a microcosm of the broader debate around executive...…
AstraZeneca pay debate exposes disparity in US-UK corporate values
Tomorrow’s shareholder vote on AstraZeneca PLC (LSE:AZN) boss Pascal Soriot’s compensation represents a microcosm of the broader debate around executive...…
BARCLAYS stuft ASTRAZENECA auf Overweight
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Astrazeneca auf "Overweight" mit einem Kursziel von 12500…
Krank nach Corona-Impfung - Astrazeneca zu Auskunft verurteilt
BAMBERG (dpa-AFX) - Im Prozess um einen mutmaßlichen Corona-Impfschaden hat eine Frau aus Oberfranken einen Teilerfolg gegen den Hersteller Astrazeneca…
Enhertu approved in US for HER2+ solid tumours
08 April 2024
Enhertu approved in the US as first tumour-agnostic HER2-directed therapy
for previously treated patients with metastatic HER2-positive solid tumours
Based on…
AstraZenecas (AZN) Enhertu Gets FDA Nod for Solid Tumors
FDA approves AstraZeneca (AZN) and partner Daiichi Sankyos Enhertu for HER2-expressing metastatic cancers based on data from three phase II…